Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 26 (BNIP3P26)

Target
BNIP3P26
Molecular classification
Other (Pseudogene)
01

Overview

BCL2 interacting protein 3 pseudogene 26 (BNIP3P26) is a pseudogene, meaning it is a non-functional segment of DNA similar in sequence to a gene coding for a protein in the BCL2-interacting protein 3 family, but it does not encode a functional protein product. BNIP3P26 is annotated in humans under NCBI Gene ID 100421699 and Ensembl ENSG00000268705. Unlike the functional BNIP3 gene, which is a member of the Bcl-2 family involved in apoptosis and mitochondrial function, BNIP3P26 does not produce an active protein and is not considered a receptor, enzyme, or therapeutic target. There is no known direct disease association or drug interaction for this pseudogene[2][4]. Pseudogenes like BNIP3P26 are generally regarded as non-coding remnants of genes and lack protein-coding potential unless proven otherwise. While some pseudogenes can have regulatory RNA roles, there is currently no evidence for BNIP3P26 functioning as a regulator, biomarker, or therapeutic target[2][4][8]. BNIP3P26 is a non-functional pseudogene, not a drug target, receptor, or enzyme. Any reference to it as a molecule/receptor for therapeutic targeting is incorrect[2][4].

Other names
BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 26BNIP3P26

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 26 (BNIP3P26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 26 (BNIP3P26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call